Hoxton Planning & Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Buy
1,255
+5
+0.4% +$5.11K 0.39% 53
2026
Q1
$1.15M Sell
1,250
-31
-2% -$31.4K 0.35% 58
2025
Q4
$1.38M Buy
1,281
+13
+1% +$12.4K 0.41% 47
2025
Q3
$967K Buy
1,268
+12
+1% +$8.93K 0.31% 61
2025
Q2
$979K Sell
1,256
-70
-5% -$54.4K 0.34% 58
2025
Q1
$1.1M Buy
1,326
+33
+3% +$27.5K 0.42% 48
2024
Q4
$998K Sell
1,293
-65
-5% -$53.8K 0.38% 47
2024
Q3
$1.2M Buy
1,358
+197
+17% +$177K 0.47% 38
2024
Q2
$1.05M Buy
1,161
+33
+3% +$26.4K 0.49% 35
2024
Q1
$878K Buy
1,128
+58
+5% +$41.3K 0.42% 43
2023
Q4
$624K Sell
1,070
-2
-0.2% -$1.17K 0.33% 53
2023
Q3
$576K Sell
1,072
-20
-2% -$10.3K 0.37% 55
2023
Q2
$512K Sell
1,092
-60
-5% -$25.2K 0.32% 62
2023
Q1
$396K Sell
1,152
-6
-0.5% -$2.02K 0.22% 93
2022
Q4
$424K Buy
+1,158
New +$411K 0.23% 92

Other funds holding LLY

Hoxton Planning & Management's LLY Position: Q2 2026 in Review

Hoxton Planning & Management increased its Eli Lilly (LLY) stake by 0.4% in Q2 2026, buying an estimated $5.11K and bringing the position to 1,255 shares worth $1.51M. The position accounts for 0.39% of the portfolio, ranked #53.

Hoxton Planning & Management first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 995 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hoxton Planning & Management held 1,255 shares of Eli Lilly worth $1.51M as of Q2 2026.
  • Hoxton Planning & Management bought 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 0.39% of Hoxton Planning & Management's portfolio in Q2 2026, its #53 holding.
  • Hoxton Planning & Management first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 995 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hoxton Planning & Management's 13F filing for Q2 2026, filed 16 Jul 2026.